How much does Iqvia Laboratories Discovery UK Ltd make?

Iqvia Laboratories Discovery UK Ltd reported revenue of £105m and a loss of £6.5m in the year to 27 Dec 2025, according to its accounts filed at Companies House.

How many employees does Iqvia Laboratories Discovery UK Ltd have?

Iqvia Laboratories Discovery UK Ltd reported an average of 637 employees in the year to 27 Dec 2025.

Is Iqvia Laboratories Discovery UK Ltd profitable?

No — Iqvia Laboratories Discovery UK Ltd reported a loss of £6.5m in the year to 27 Dec 2025.

Company No. 04622227 · Incorporated 19 Dec 2002

Iqvia Laboratories Discovery UK Ltd

Registered name: IQVIA LABORATORIES DISCOVERY UK LTD

Part of Charles River Nederland Bv group

Iqvia Laboratories Discovery UK Ltd made £105m revenue and a £6.5m loss in the year to 27 Dec 2025.

Iqvia Laboratories Discovery UK Ltd’s revenue fell 2% to £105m in the year to 27 Dec 2025, with a loss of £6.5m and 637 employees. The company is classified under “research and experimental development on biotechnology” and is based in Reading; we hold 3 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 72110Research and experimental development on biotechnology

Status: Active
Location: Reading, South East
Age: 23 yrs · since 2002
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 27 Dec 2025

Key figures

Revenue

£105m

Growth ▼1.7%

Profit

−£6.5m

Growth —

Profit margin

−6.2%

Gross 24.6%

Employees

637

Change ▼9.8%

Profit / employee

−£10.2k

Revenue/employee £164k

Profitable streak

0yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Dec 2023	28 Dec 2024	27 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£120m	£106m	£105m
Cost of sales	£88.6m	£78.6m	£78.8m
Gross profit	£31.3m	£27.6m	£25.7m
Operating profit	£12.1m	£95k	−£2.8m
Profit before tax	£10.2m	−£1.1m	−£3.8m
Profit after tax	£7.8m	−£3.9m	−£6.5m
Profit (best available)	£7.8m	−£3.9m	−£6.5m
Staff costs	£44.7m	£43.2m	£43.1m
Employees (average)	768	706	637
Ratios
Profit margin	6.5%	−3.7%	−6.2%
Gross margin	26.1%	26%	24.6%
Revenue per employee	£156k	£151k	£164k
Profit per employee	£10.2k	−£5.5k	−£10.2k
Growth (year on year)
Revenue growth	—	▼11.4%	▼1.7%
Profit growth	—	▼149.6%	—
Headcount growth	—	▼8.1%	▼9.8%
Balance sheet — indirect signals, not revenue
Net assets	£66.5m	£61.7m	£55.6m
Fixed assets	£65.3m	£54.9m	£52.5m
Current assets	£56.9m	£56.8m	£50.3m
Debtors	£17.5m	£14.4m	£14.7m
Deferred income	£9.6m	£12.5m	£16.4m
Source	Full · bulk data Sep 2025	Full · bulk data Sep 2025	Full · bulk data Jul 2026

Derived from the latest filing

How the business works

Profit margin: −6.2%; Profit ÷ revenue.
Gross margin: 24.6%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £164k; Revenue ÷ average employees.
Profit per employee: −£10.2k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 50.2%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 15.7%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 14.1%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▼10%; Now £55.6m
Cash at bank: —; Now —
Headcount: ▼10%; Now 637
Deferred income: ▲31%; Now £16.4m
Fixed assets: ▼4%; Now £52.5m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Charles River Nederland Bv (registered outside the UK register)ultimate parent75–100%
Charles River Laboratories Holdings Limited75–100%
Biofocus Dpi (Holdings) Ltd75–100%
Iqvia Laboratories Discovery UK Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (1)

Charles River Laboratories England LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from Full for the year to 27 Dec 2025 (profit −£6.5m), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.